Ocugen Establishes Vaccine Scientific Advisory Board

Leading experts to evaluate the clinical and regulatory path to approval in the US market of COVAXIN™, a whole-virion inactivated COVID-19 vaccine Leading experts to evaluate the clinical and regulatory path to approval in the US market of COVAXIN™, a whole-virion inactivated COVID-19 vaccine

See the original post:
Ocugen Establishes Vaccine Scientific Advisory Board

Related Post